Tyvaso 64 MCG kit
Ended Awarded
- Contract number
- 36C24526N0333
- Awardee
-
United Therapeutics Corp UEI KK5FBFA43JS7
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $17,352
Award facts
- Contract value 100% obligated
- $17,351.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Bartlett, TN 38134, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of Veterans Affairs, Veterans Integrated Service Network 5 (VISN 5), awarded a delivery order valued at $17,351.60 to United Therapeutics Corp for Tyvaso 64 microgram inhalation kits on February 18, 2026. This firm fixed-price delivery order, which has an ultimate completion date of February 25, 2026, will be performed in Bartlett, Tennessee. The award was issued without a set-aside designation and represents a continuation of the VA's established pharmaceutical procurement relationship with United Therapeutics through the General Services Administration's Federal Supply Schedule for Pharmaceuticals and Drugs (FSS-61-IB).
This delivery order is executed under a larger single-award Blanket Purchase Agreement between the Department of Veterans Affairs National Acquisition Center and United Therapeutics Corp, valued at $207.1 million with a ceiling date of April 23, 2026. The BPA encompasses four critical pharmaceutical products—Unituxin, Remodulin, Tyvaso, and Orenitram—which are essential treatments for pulmonary arterial hypertension and select oncology conditions affecting the veteran population. The single-award structure enables Veterans Integrated Service Networks across the country to procure these specialized medications at pre-negotiated firm-fixed prices, providing supply chain efficiency and cost predictability while ensuring reliable access to these critical therapeutic products throughout the VA's integrated healthcare network.
Quick answers
Who was awarded contract 36C24526N0333?
36C24526N0333 was awarded to United Therapeutics Corp by Veterans Integrated Service Network 5 (Veterans Health Administration) on February 18, 2026.
How much is contract 36C24526N0333 worth?
The government has obligated $17,352 on 36C24526N0333.
Is contract 36C24526N0333 an order under another contract?
Yes. 36C24526N0333 is a delivery order under 36F79720D0104, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24526N0333 competed?
The extent of competition for 36C24526N0333 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award